Updated: May 19, 2026

Andrew I Koven

MTVAMetaVia Inc.SEC CIK: 0001258673
Estimated Net Worth
$6.97 Million
Last Updated: May 19, 2026 02:44 AM EST

Transaction Summary

Total Transactions63
Buy-Sell Ratio2.06
Buy Transactions37
Sell Transactions18

Transaction Volume

Total Volume$27.07M
Net Volume-$6.29M
Buy Volume$10.39M
Sell Volume$16.68M

Trade Analysis

AVG Trade Size$429.7K
Largest Trade$8.49M
Most Active MonthJun
Most Active Year2017

Trading Sentiment

OverallBearish
Recent TradeBuying
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading chart

Monthly Trading Pattern

Loading chart

Past Insider Trading and Trends

Andrew I Koven has an estimated net worth of $6.97 Million. This is based on reported shares across multiple companies, which include NEUROLOGIX INC/DE, NeuroBo Pharmaceuticals, Inc., KALA BIO, Inc., Aralez Pharmaceuticals Inc., AUXILIUM PHARMACEUTICALS INC, POZEN INC /NC, SEPRACOR INC /DE/, KOS PHARMACEUTICALS INC, and INSPIRE PHARMACEUTICALS INC.



2014 was Andrew I Koven's most active year for acquiring shares with 8 total transactions. Andrew I Koven's most active month to acquire stocks was the month of May. 2005 was Andrew I Koven's most active year for disposing of shares, totalling 8 transactions. Andrew I Koven's most active month to dispose stocks was the month of April. 2007 saw Andrew I Koven paying a total of $4,947,000.00 for 100,000 shares, this is the most they've acquired in one year. In 2015 Andrew I Koven cashed out on 232,446 shares for a total of $8,491,252.38, their largest year based on trade value.

Holdings & Transactions

Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…